Financials Eyenovia, Inc.

Equities

EYEN

US30234E1047

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-05-17 pm EDT 5-day change 1st Jan Change
0.7499 USD -8.65% Intraday chart for Eyenovia, Inc. -2.77% -63.95%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 76.61 150.8 113.6 58.88 91.77 40.4 - -
Enterprise Value (EV) 1 76.61 150.8 113.6 58.88 91.77 40.4 40.4 40.4
P/E ratio -3.05 x -6.45 x -8.16 x -1.96 x -3.15 x -1.1 x -0.84 x -1.47 x
Yield - - - - - - - -
Capitalization / Revenue - 75.4 x 8.12 x - 24,215 x 11.4 x 3.48 x 1.15 x
EV / Revenue - 75.4 x 8.12 x - 24,215 x 11.4 x 3.48 x 1.15 x
EV / EBITDA -3.6 x - -8.96 x - - -0.63 x -0.59 x -
EV / FCF - -22.7 x - -2.27 x - -1.14 x -1.09 x -2.07 x
FCF Yield - -4.41% - -44.1% - -88% -92% -48.2%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 17,101 24,884 28,407 36,121 44,122 53,871 - -
Reference price 2 4.480 6.060 4.000 1.630 2.080 0.7499 0.7499 0.7499
Announcement Date 3/25/20 3/25/21 3/28/22 3/30/23 3/18/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 2 14 - 0.00379 3.541 11.6 35.08
EBITDA 1 -21.29 - -12.68 - - -64.58 -68.67 -
EBIT 1 -21.31 -19.79 -12.9 -26.91 -25.41 -29.47 -41.31 -23.02
Operating Margin - -989.46% -92.17% - -670,354.88% -832.15% -356.07% -65.63%
Earnings before Tax (EBT) 1 -21.16 -19.77 -12.78 -28.01 -27.26 -31.84 -42.6 -24.34
Net income 1 -21.16 -19.77 -12.78 -28.01 -27.26 -31.84 -42.3 -24.34
Net margin - -988.49% -91.27% - -719,290.24% -899.12% -364.62% -69.4%
EPS 2 -1.470 -0.9400 -0.4900 -0.8300 -0.6600 -0.6800 -0.8950 -0.5100
Free Cash Flow 1 - -6.646 - -25.98 - -35.55 -37.17 -19.47
FCF margin - -332.28% - - - -1,003.85% -320.39% -55.52%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/25/20 3/25/21 3/28/22 3/30/23 3/18/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 10 - - - - - - 0.0012 0.00259 0.00499 0.7618 1.097 1.679 1.55 1.844
EBITDA 3.187 -6.203 -6.014 -6.218 - - - - - - - - - - -
EBIT 1 3.113 -7.188 -7.121 -7.23 -5.372 -5.459 -5.961 -6.52 -7.467 -8.267 -6.642 -6.712 -6.702 -6.65 -6.496
Operating Margin 31.13% - - - - - - -543,349.17% -288,283.78% -165,667.74% -871.94% -612.02% -399.15% -429.03% -352.28%
Earnings before Tax (EBT) 1 2.983 -7.34 -7.239 -7.309 -6.123 -5.739 -6.216 -7.339 -7.967 -10.92 -6.928 -7 -6.991 -6.6 -6.446
Net income 1 2.983 -7.34 -7.239 -7.309 -6.123 -5.739 -6.216 -7.339 -7.967 -10.92 -6.928 -7 -6.991 -6.6 -6.446
Net margin 29.83% - - - - - - -611,560.83% -307,611.58% -218,879.76% -909.53% -638.28% -416.38% -425.81% -349.57%
EPS 2 0.1000 -0.2400 -0.2200 -0.2100 -0.1700 -0.1500 -0.1600 -0.1800 -0.1600 -0.2300 -0.1500 -0.1500 -0.1500 -0.1400 -0.1300
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 3/28/22 5/12/22 8/10/22 11/10/22 3/30/23 5/12/23 8/10/23 11/13/23 3/18/24 5/15/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - -6.65 - -26 - -35.5 -37.2 -19.5
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - 0.26 - 0.87 - 4 4 4
Capex / Sales - 13.06% - - - 112.95% 34.48% 11.4%
Announcement Date 3/25/20 3/25/21 3/28/22 3/30/23 3/18/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.7499 USD
Average target price
9 USD
Spread / Average Target
+1,100.16%
Consensus
  1. Stock Market
  2. Equities
  3. EYEN Stock
  4. Financials Eyenovia, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW